FOCINVEZ Trademark

Trademark Overview

On Friday, April 22, 2022, a trademark application was filed for FOCINVEZ with the United States Patent and Trademark Office. The USPTO has given the FOCINVEZ trademark a serial number of 97376937. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Tuesday, August 19, 2025. This trademark is owned by Spes Pharmaceuticals Inc.. The FOCINVEZ trademark is filed in the Advertising, Business and Retail Services category with the following description:

Brand development and evaluation services in the field of pharmaceutical and healthcare industries and medical fields
focinvez

General Information

Serial Number97376937
Word MarkFOCINVEZ
Filing DateFriday, April 22, 2022
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateTuesday, August 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements

Goods and ServicesBrand development and evaluation services in the field of pharmaceutical and healthcare industries and medical fields

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, April 27, 2022
Primary Code035
First Use Anywhere DateMonday, July 1, 2024
First Use In Commerce DateMonday, July 1, 2024

Trademark Owner History

Party NameSpes Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPlainsboro, NJ 08536
Party NameSpes Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Brunswick, NJ 08902

Trademark Events

Event DateEvent Description
Tuesday, April 26, 2022NEW APPLICATION ENTERED
Wednesday, April 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 9, 2023ASSIGNED TO EXAMINER
Friday, February 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 7, 2023SOU EXTENSION 1 FILED
Tuesday, November 7, 2023SOU EXTENSION 1 GRANTED
Thursday, November 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 2 FILED
Monday, April 29, 2024SOU EXTENSION 2 GRANTED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2024SOU TEAS EXTENSION RECEIVED
Thursday, November 7, 2024SOU EXTENSION 3 GRANTED
Tuesday, April 1, 2025USE AMENDMENT FILED
Tuesday, April 1, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, July 9, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 9, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 19, 2025SU - NON-FINAL ACTION - WRITTEN
Tuesday, August 19, 2025NON-FINAL ACTION E-MAILED
Tuesday, August 19, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2024SOU EXTENSION 3 FILED

Related Keywords

focinvez healthcare industries medical fields pharmaceutical field development evaluation services brand